Request for Information (RFI): Input on Report From Council of Councils on Assessing the Safety of Relocating At-Risk Chimpanzees, 27012-27013 [2018-12458]

Download as PDF 27012 Federal Register / Vol. 83, No. 112 / Monday, June 11, 2018 / Notices daltland on DSKBBV9HB2PROD with NOTICES information gathered by the Department of Health and Human Services and the Department of Justice with regard to safety, efficacy, and abuse potential of drugs or other substances, and recommends actions to be taken by the Department of Health and Human Services with regard to the marketing, investigation, and control of such drugs or other substances. The Committee shall consist of a core of 11 voting members including the Chair. Members and the Chair are selected by the Commissioner or designee from among authorities knowledgeable in the fields of risk communication, risk management, drug safety, medical, behavioral, and biological sciences as they apply to risk management, and drug abuse. Members will be invited to serve for overlapping terms of up to 4 years. Almost all nonFederal members of this committee serve as Special Government Employees. The core of voting members may include one technically qualified member, selected by the Commissioner or designee, who is identified with consumer interests and is recommended by either a consortium of consumeroriented organizations or other interested persons. In addition to the voting members, the Committee may include one non-voting member who is identified with industry interests. Further information regarding the most recent charter and other information can be found at https:// www.fda.gov/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/ DrugSafetyandRiskManagement AdvisoryCommittee/default.htm or by contacting the Designated Federal Officer (see FOR FURTHER INFORMATION CONTACT). In light of the fact that no change has been made to the committee name or description of duties, no amendment will be made to 21 CFR 14.100. This document is issued under the Federal Advisory Committee Act (5 U.S.C. app.). For general information related to FDA advisory committees, please check https://www.fda.gov/ AdvisoryCommittees/default.htm. Dated: June 5, 2018. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2018–12442 Filed 6–8–18; 8:45 am] BILLING CODE 4164–01–P VerDate Sep<11>2014 19:19 Jun 08, 2018 Jkt 244001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Council on Graduate Medical Education Health Resources and Service Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice of Advisory Council meeting. AGENCY: In accordance with the Federal Advisory Committee Act, this notice announces a public meeting of the Council on Graduate Medical Education (COGME). This notice is being published less than 15 days prior to the meeting date due to unforeseen administrative delays. DATES: Wednesday, June 20, 2018, from 8:30 a.m. to 5:00 p.m. ET, and Thursday, June 21, 2018, from 8:30 a.m. to 2:00 p.m. ET. ADDRESSES: This meeting is an in person meeting and will offer virtual access through teleconference and webinar. The address for the meeting is 5600 Fishers Lane, Rockville, Maryland 20857. • The conference call-in number is 1– 800–619–2521; passcode: 9271697. • The webinar link is https:// hrsa.connectsolutions.com/cogme. FOR FURTHER INFORMATION CONTACT: Kennita R. Carter, MD, Designated Federal Official, Division of Medicine and Dentistry, Bureau of Health Workforce, HRSA, Address: 5600 Fishers Lane, 15N–116, Rockville, Maryland 20857; (2) call 301–945–3505; or (3) send an email to KCarter@ hrsa.gov. SUMMARY: SUPPLEMENTARY INFORMATION: Background: COGME provides advice and recommendations to the Secretary of HHS and to Congress on a range of issues, including: The nature and financing of medical education training; the development of performance measures and longitudinal evaluation methods of medical education programs; foreign medical school graduates; and the supply and distribution of the physician workforce in the United States, including any projected shortages or excesses. COGME submits reports to the Secretary of HHS; the Senate Committee on Health, Education, Labor, and Pensions; and the House of Representatives Committee on Energy and Commerce. Agenda: During the meeting, the COGME members will discuss the strategic directions of the Council and PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 issues related to physician workforce development and graduate medical education, leading to selection a topic for its 24th Report to Congress. An agenda will be available on the COGME website https://www.hrsa.gov/ advisorycommittees/bhpradvisory/ COGME/ prior to the meeting. Please note that agenda items are subject to change as priorities dictate. Public Participation: Members of the public will have the opportunity to provide comments. Public participants may submit written statements in advance of the scheduled meeting. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to provide written statements or make oral comments to the COGME should be sent to Dr. Kennita R. Carter. Since this meeting is held in a Federal government building, attendees must go through a security check to enter the building. Non-U.S. Citizen attendees must notify HRSA of their planned attendance at least 10 workdays prior to the meeting in order to facilitate their entry into the building. All attendees are required to present government-issued identification prior to entry. Individuals who plan to participate and require special assistance, such as sign language interpretation or other reasonable accommodations, should notify Dr. Kennita Carter, using the address and phone number above at least 10 business days prior to the meeting. Amy P. McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2018–12512 Filed 6–8–18; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Request for Information (RFI): Input on Report From Council of Councils on Assessing the Safety of Relocating AtRisk Chimpanzees AGENCY: National Institutes of Health, HHS. ACTION: Notice. The National Institutes of Health (NIH) is informing the research community and other interested parties that it received from the NIH Council of Councils the report of its Working Group on Assessing the Safety of Relocating At-Risk Chimpanzees, and the agency will consider recommendations contained in the report (see https://dpcpsi.nih.gov/sites/ SUMMARY: E:\FR\FM\11JNN1.SGM 11JNN1 daltland on DSKBBV9HB2PROD with NOTICES Federal Register / Vol. 83, No. 112 / Monday, June 11, 2018 / Notices default/files/CoC_May_2018_WG_ Report_508.pdf). The NIH invites public comment in response to this Request for Information (RFI). DATES: This Request for Information is open for public comment for a period of 60 days. Comments must be submitted by August 10, 2018 to ensure consideration. ADDRESSES: Comments must be submitted electronically using the webbased form available at https:// grants.nih.gov/grants/rfi/rfi.cfm?ID=72. FOR FURTHER INFORMATION CONTACT: Please direct all inquiries to the Division of Program Coordination, Planning, and Strategic Initiatives at dpcpsi@od.nih.gov. SUPPLEMENTARY INFORMATION: Background: In 2015, the NIH decided that all NIH-owned chimpanzees residing outside of the federal chimpanzee sanctuary system were eligible for retirement and relocation to the sanctuary. This decision was based on several converging efforts: • A 2011 report by the Institute of Medicine (IOM) that stated the use of chimpanzees in research has become ‘‘largely unnecessary’’ and recommended approaches to minimize their use in federally funded research. • A 2013 report from an earlier NIH Council of Councils working group that made recommendations to the NIH on implementing the IOM principles and guidelines and placement of NIH-owned or -supported chimpanzees. • A 2015 announcement by the U.S. Fish and Wildlife Service, designating all captive chimpanzees as endangered, thereby conferring specific protections under the Endangered Species Act. • Observations by the NIH of a significantly reduced demand for chimpanzees for research. A priority for the NIH, relocation of the chimpanzees to the sanctuary proceeds according to a retirement plan prepared by the NIH. The retirement plan, as well as the November 2015 NIH announcement, state that chimpanzees will be retired to the sanctuary once space becomes available and on a timescale that considers the health, welfare, and social grouping of individual chimpanzees. However, many of these chimpanzees have agerelated ailments that can increase their risk of severe adverse events during the transfer and relocation process. On January 26, 2018, the NIH Council of Councils established a Working Group on Assessing the Safety of Relocating At-Risk Chimpanzees to provide advice and recommendations to the Council on factors to be considered by attending veterinarian staff when VerDate Sep<11>2014 19:19 Jun 08, 2018 Jkt 244001 deciding whether to relocate NIHowned or -supported at-risk chimpanzees to the federal sanctuary system. On May 18, 2018, the working group submitted the report to the NIH Council of Councils, which subsequently approved the report and transmitted it to the NIH for consideration. Information Requested: The NIH is seeking input on the recommendations (see https://dpcpsi.nih.gov/sites/default/ files/CoC_May_2018_WG_Report_ 508.pdf) from the biomedical research community, including foundations, scientific societies, government and regulatory agencies, industry, NIH grantee institutions, and from other members of the public. Responders are free to address any or all recommendations. How to Submit a Response: All comments must be submitted electronically to https://grants.nih.gov/ grants/rfi/rfi.cfm?ID=72. Comments must pertain to the category for which feedback is requested, conform to the word limit indicated, and be submitted by the specified due date. You will see an electronic confirmation acknowledging receipt of your response but will not receive individualized feedback on any suggestions. Response to this RFI is voluntary. No basis for claims against the U.S. Government shall arise as a result of a response to this RFI or from the Government’s use of such information. Please note that the Government will not pay for response preparation or for the use of any information contained in the response. The NIH may make all responses available, including name of the responder, without notifying the respondent. In addition, the NIH may prepare and make available a summary of all input received which is responsive to this RFI. Dated: June 4, 2018. Lawrence A. Tabak, Deputy Director, National Institutes of Health. [FR Doc. 2018–12458 Filed 6–8–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Agency Information Collection Activities: Homeland Security Acquisition Regulation (HSAR) Various Forms Office of the Chief Procurement Officer, Department of Homeland Security (DHS). AGENCY: PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 27013 30-Day notice and request for comments; Extension of a Currently Approved Collection, 1600–0002. ACTION: The DHS Office of the Chief Procurement Officer will submit the following Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995. The purpose of the information collected is to ensure proper closing of physically complete contracts. The information will be used by DHS contracting officers to ensure compliance with terms and conditions of DHS contracts and to complete reports required by other Federal agencies such as the General Services Administration (GSA) and the Department of Labor (DOL). If this information is not collected, DHS could inadvertently violate statutory or regulatory requirements and DHS’s interests concerning inventions and contractors’ claims would not be protected. DHS previously published this ICR in the Federal Register on Tuesday, March 6, 2018 for a 60-day public comment period. Six unrelated comments were received by DHS. The purpose of this notice is to allow an additional 30 days for public comments. DATES: Comments are encouraged and will be accepted until July 11, 2018. This process is conducted in accordance with 5 CFR 1320.1. ADDRESSES: Interested persons are invited to submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget. Comments should be addressed to OMB Desk Officer, Department of Homeland Security and sent via electronic mail to dhsdeskofficer@ omb.eop.gov. SUMMARY: This information collection is associated with the forms listed below and is necessary to implement applicable parts of the HSAR (48 CFR Chapter 30). There are four forms under this collection of information request that are used by offerors, contractors, and the general public to comply with requirements in contracts awarded by DHS. The information collected is used by contracting officers to ensure compliance with terms and conditions of DHS contracts. The forms are as follows: 1. DHS Form 0700–01, Cumulative Claim and Reconciliation Statement (see (HSAR) 48 CFR 3004.804– 507(a)(3) SUPPLEMENTARY INFORMATION: E:\FR\FM\11JNN1.SGM 11JNN1

Agencies

[Federal Register Volume 83, Number 112 (Monday, June 11, 2018)]
[Notices]
[Pages 27012-27013]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12458]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Request for Information (RFI): Input on Report From Council of 
Councils on Assessing the Safety of Relocating At-Risk Chimpanzees

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Institutes of Health (NIH) is informing the 
research community and other interested parties that it received from 
the NIH Council of Councils the report of its Working Group on 
Assessing the Safety of Relocating At-Risk Chimpanzees, and the agency 
will consider recommendations contained in the report (see https://
dpcpsi.nih.gov/sites/

[[Page 27013]]

default/files/CoC_May_2018_WG_Report_508.pdf). The NIH invites public 
comment in response to this Request for Information (RFI).

DATES: This Request for Information is open for public comment for a 
period of 60 days. Comments must be submitted by August 10, 2018 to 
ensure consideration.

ADDRESSES: Comments must be submitted electronically using the web-
based form available at https://grants.nih.gov/grants/rfi/rfi.cfm?ID=72.

FOR FURTHER INFORMATION CONTACT: Please direct all inquiries to the 
Division of Program Coordination, Planning, and Strategic Initiatives 
at [email protected].

SUPPLEMENTARY INFORMATION: 
    Background: In 2015, the NIH decided that all NIH-owned chimpanzees 
residing outside of the federal chimpanzee sanctuary system were 
eligible for retirement and relocation to the sanctuary. This decision 
was based on several converging efforts:
     A 2011 report by the Institute of Medicine (IOM) that 
stated the use of chimpanzees in research has become ``largely 
unnecessary'' and recommended approaches to minimize their use in 
federally funded research.
     A 2013 report from an earlier NIH Council of Councils 
working group that made recommendations to the NIH on implementing the 
IOM principles and guidelines and placement of NIH-owned or -supported 
chimpanzees.
     A 2015 announcement by the U.S. Fish and Wildlife Service, 
designating all captive chimpanzees as endangered, thereby conferring 
specific protections under the Endangered Species Act.
     Observations by the NIH of a significantly reduced demand 
for chimpanzees for research.
    A priority for the NIH, relocation of the chimpanzees to the 
sanctuary proceeds according to a retirement plan prepared by the NIH. 
The retirement plan, as well as the November 2015 NIH announcement, 
state that chimpanzees will be retired to the sanctuary once space 
becomes available and on a timescale that considers the health, 
welfare, and social grouping of individual chimpanzees. However, many 
of these chimpanzees have age-related ailments that can increase their 
risk of severe adverse events during the transfer and relocation 
process.
    On January 26, 2018, the NIH Council of Councils established a 
Working Group on Assessing the Safety of Relocating At-Risk Chimpanzees 
to provide advice and recommendations to the Council on factors to be 
considered by attending veterinarian staff when deciding whether to 
relocate NIH-owned or -supported at-risk chimpanzees to the federal 
sanctuary system. On May 18, 2018, the working group submitted the 
report to the NIH Council of Councils, which subsequently approved the 
report and transmitted it to the NIH for consideration.
    Information Requested: The NIH is seeking input on the 
recommendations (see https://dpcpsi.nih.gov/sites/default/files/CoC_May_2018_WG_Report_508.pdf) from the biomedical research community, 
including foundations, scientific societies, government and regulatory 
agencies, industry, NIH grantee institutions, and from other members of 
the public. Responders are free to address any or all recommendations.
    How to Submit a Response: All comments must be submitted 
electronically to https://grants.nih.gov/grants/rfi/rfi.cfm?ID=72. 
Comments must pertain to the category for which feedback is requested, 
conform to the word limit indicated, and be submitted by the specified 
due date. You will see an electronic confirmation acknowledging receipt 
of your response but will not receive individualized feedback on any 
suggestions.
    Response to this RFI is voluntary. No basis for claims against the 
U.S. Government shall arise as a result of a response to this RFI or 
from the Government's use of such information. Please note that the 
Government will not pay for response preparation or for the use of any 
information contained in the response. The NIH may make all responses 
available, including name of the responder, without notifying the 
respondent. In addition, the NIH may prepare and make available a 
summary of all input received which is responsive to this RFI.

    Dated: June 4, 2018.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2018-12458 Filed 6-8-18; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.